I.G. Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

I.G. Investment Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-71,750	Closed	-$1.51M	–	934
2015 Q3	$1.51M	Sell	71,750 -10,570	-13%	-$362K	0.01%	531
2015 Q2	$4.08M	Buy	82,320 +23,410	+40%	+$1.4M	0.02%	391
2015 Q1	$4.61M	Sell	58,910 -43,540	-42%	-$2.7M	0.02%	364
2014 Q4	$6.21M	Sell	102,450 -32,840	-24%	-$1.65M	0.02%	312
2014 Q3	$5.76M	Buy	135,290 +26,200	+24%	+$1.41M	0.02%	315
2014 Q2	$6.74M	Buy	109,090 +30,490	+39%	+$1.77M	0.02%	298
2014 Q1	$5.11M	Sell	78,600 -4,000	-5%	-$271K	0.02%	333
2013 Q4	$4.65M	Buy	+82,600	New	+$4.64M	0.02%	341

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

I.G. Investment Management's OREX Position: Q4 2015 in Review

I.G. Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q4 2015, closing a stake of 71,750 shares — an estimated $1.51M sold.

I.G. Investment Management first reported a position in OREX in Q4 2013 and held it in 8 quarters. The position peaked at $6.74M in Q2 2014. 121 funds tracked by Wall St. Rank hold OREX as of Q4 2015.

I.G. Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
I.G. Investment Management sold 71,750 Orexigen Therapeutics, Inc. shares in Q4 2015, an estimated $1.51M.
I.G. Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 8 quarters.
I.G. Investment Management's Orexigen Therapeutics, Inc. position peaked at $6.74M in Q2 2014.
121 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2015.

Based on I.G. Investment Management's 13F filing for Q4 2015, filed 10 Feb 2016.